19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Claudia Hattinger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma

Belisario, D. C., Akman, M., Godel, M., Campani, V., Patrizio, M. P., Scotti, L., Hattinger, C. M., De Rosa, G. D., Donadelli, M., Serra, M., Kopecka, J. & Riganti, C., Mar 6 2020, In : Cells. 9, 3

Research output: Contribution to journalArticle

  • Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma

    Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., Robison, L. L., Armstrong, G. T., Bhatia, S., Song, L., Pankratz, N., Pinheiro, M., Gastier-Foster, J. M., Gorlick, R., de Toledo, S. R. C., Petrilli, A. S. & 30 others, Patino-Garcia, A., Lecanda, F., Gutierrez-Jimeno, M., Serra, M., Hattinger, C., Picci, P., Scotlandi, K., Flanagan, A. M., Tirabosco, R., Amary, M. F., Kurucu, N., Ilhan, I. E., Ballinger, M. L., Thomas, D. M., Barkauskas, D. A., Mejia-Baltodano, G., Valverde, P., Hicks, B. D., Zhu, B., Wang, M., Hutchinson, A. A., Tucker, M., Sampson, J., Landi, M. T., Freedman, N. D., Gapstur, S., Carter, B., Hoover, R. N., Chanock, S. J. & Savage, S. A., Mar 19 2020, In : JAMA oncology.

    Research output: Contribution to journalArticle

  • An update on emerging drugs in osteosarcoma: towards tailored therapies?

    Hattinger, C. M., Patrizio, M. P., Magagnoli, F., Luppi, S. & Serra, M., Sep 2019, In : Expert Opinion on Emerging Drugs. 24, 3, p. 153-171 19 p.

    Research output: Contribution to journalArticle

  • Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment

    Hattinger, C. M., Patrizio, M. P., Luppi, S., Magagnoli, F., Picci, P. & Serra, M., Apr 1 2019, In : Expert opinion on drug metabolism & toxicology. 15, 4, p. 299-311 13 p.

    Research output: Contribution to journalArticle

  • Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts

    Gazzano, E., Buondonno, I., Marengo, A., Rolando, B., Chegaev, K., Kopecka, J., Saponara, S., Sorge, M., Hattinger, C. M., Gasco, A., Fruttero, R., Brancaccio, M., Serra, M., Stella, B., Fattal, E., Arpicco, S. & Riganti, C., Aug 2019, In : Cancer Letters. 456, p. 29-39 11 p.

    Research output: Contribution to journalArticle